Weimai Medical Technology (Wuxi) Co., Ltd. announced that it has received round of funding led by new investor CDH Investment Management Company Limited on March 15, 2024. The transaction included the participation from returning investor Yunnan Botanee Bio-Technology Group Co.LTD.